There are about five companies producing vaccines right now. I gave the example of ZOSTAVAX, but there are other examples as well. There is a vaccine against rotavirus. It is not yet funded, but it has been approved for four years already. It has received a favourable opinion from the National Advisory Committee. Moreover, the Canadian Pediatric Society has just recommended it. But there is no public funding yet for it.
To ensure funding for these vaccines, the provinces need some financial help, in my opinion. Other companies are developing vaccines, and a number of those will soon be ready. In Canada, we need to put a lot more emphasis on prevention. It is not an expense but rather an investment. It prevents hospitalization costs, saves lives and prevents the entire health care system from being overburdened.